GPT and metabolic dysfunction-associated steatohepatitis: Compared to healthy controls, NASH patients of the different study cumulatively assessed at baseline, showed increased height, body weight, BMI, ALT, and blood glucose, and decreased LDL and HDL cholesterol (Supplementary Table S1).